Clinical trial
An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients…
NCT00201357 · National Health Research Institutes, Taiwan, Other · Completed
Key facts
| NCT number | NCT00201357 |
|---|---|
| Title | An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer |
| Official title | An Open, Non-Comparative Trial to Assess the Efficacy and Safety of Oral Thalidomide (THADO) in Patientswith Hormone-Refractory Prostate Cancer-A PHASE II CLINICAL TRIAL |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hormone-refractory Prostate Cancer |
| Intervention type | Drug |
| Interventions | Thalidomide (THADO) |
| Enrollment | 30 |
| Start date | Oct 1, 2002 |
| Primary completion | Jul 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 25, 2016 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: